Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

An assessment of patient-reported outcomes for men with erectile dysfunction: Pfizer's perspective

International Journal of Impotence Research volume 20, pages 343–357 (2008)Cite this article

Abstract

Patient-reported outcomes (PROs) for men with erectile dysfunction (ED) have blossomed in the published literature and at professional conferences. These outcomes have been central to study the science of ED itself and to evaluate efficacy of treatment for men with ED. In this review article we highlight and distinguish among seven key PROs: the International Index of Erectile Function, for sexual function including erectile function; the Sexual Health Inventory for Men (SHIM), for diagnosis of ED; the Quality of Erection Questionnaire, for satisfaction with quality of erections; the Erectile Dysfunction Inventory of Treatment Satisfaction, for personal evaluation of treatment received; the Self-Esteem And Relationship questionnaire, for emotional well-being; the Erection Hardness Score (EHS), for targeting erection hardness and the Sexual Experience Questionnaire, for erection (both function and quality), individual satisfaction and couples satisfaction. Depending on the purpose of the investigation, all seven PROs have merit for use in clinical trials and at least deserve consideration in clinical practice. The SHIM and the EHS, given their aims and brevity, deserve special consideration in clinical practice. As a unit these seven PROs complement and supplement each other. Which ones to choose in a particular undertaking depends on the objective or purpose of a given study. These PROs acknowledge that sexual dysfunction and its treatment have multiple dimensions. Each of these instruments represents a significant contribution to sexual medicine research and, when used judiciously and appropriately, can help to provide optimal patient care and management.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Committee on Quality of Health Care in America, Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. National Academy Press: Washington, DC, 2001.

  2. Acquadro C, Berzon R, Dubois D, Leidy NK, Marquis P, Revicki D et al. Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. Value Health 2003; 6: 522–531.

    Article  PubMed  Google Scholar 

  3. Fairclough DL . Patient reported outcomes as endpoints in medical research. Stat Methods Med Res 2004; 13: 115–138.

    Article  PubMed  Google Scholar 

  4. Wiklund I . Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life. Fundam Clin Pharmacol 2004; 18: 351–363.

    Article  CAS  PubMed  Google Scholar 

  5. U.S. Food and Drug Administration. Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims (DRAFT). U.S. Department of Health and Human Services, Food and Drug Administration: Center for Drug Evaluation and Research (CDER); Center for Biologics Evaluation and Research (CBER); Center for Devices and Radiological Health (CDRH).February 2006. Available at http://www.fda.gov/cder/guidance/5460dft.htm.[accessed 6 January 2008].

  6. Rothman ML, Beltran P, Cappelleri JC, Lipscomb J, Teschendorf B, the Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group. Patient-reported outcomes: conceptual issues. Value Health 2007; 10 (Suppl 2): S66–S75.

    Article  PubMed  Google Scholar 

  7. Sloan JA, Halyard MY, Frost MH, Dueck AC, Teschendorf B, Rothman ML, the Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group. The Mayo Clinic manuscript series relative to the discussion, dissemination, and operationalization of the Food and Drug Administration guidance on patient-reported outcomes. Value Health 2007; 10 (Suppl 2): S59–S63.

    Article  PubMed  Google Scholar 

  8. Snyder CF, Watson ME, Jackson JD, Cella D, Halyard MY, the Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group. Patient-reported outcomes instruction selection: designing a measurement strategy. Value Health 2007; 10 (Suppl 2): S76–S85.

    Article  PubMed  Google Scholar 

  9. Turner RR, Quittner AL, Parasuraman BM, Kallich JD, Cleeland CS, the Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group. Patient-reported outcomes: instrument development and selection issues. Value Health 2007; 10 (Suppl 2): S86–S93.

    Article  PubMed  Google Scholar 

  10. Frost MH, Reeve BB, Liepa AM, Reeve BB, Stauffer JW, Hays RD, the Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group. What is sufficient evidence for the reliability and validity of patient-reported outcomes? Value Health 2007; 10 (Suppl 2): S94–S105.

    Article  PubMed  Google Scholar 

  11. Sloan JA, Dueck AC, Erickson PA, Guess H, Revicki DA, Santanello NC, the Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group. Analysis and interpretation of results based on patient-reported outcomes. Value Health 2007; 10 (Suppl 2): S106–S115.

    Article  PubMed  Google Scholar 

  12. Revicki DA, Erickson PA, Sloan JA, Dueck A, Guess H, Santanello NC, the Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group. Interpreting and reporting results based on patient-reported outcomes. Value Health 2007; 10 (Suppl 2): S116–S124.

    Article  PubMed  Google Scholar 

  13. Patrick DL, Burke LB, Power JH, Scott JA, Rock EP, Dawisha S et al. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health 2007; 10 (Suppl 2): S125–S137.

    Article  PubMed  Google Scholar 

  14. McDowell I . Measuring Health: A Guide to Rating Scales and Questionnaires. Oxford University Press: New York, NY, 2006.

    Book  Google Scholar 

  15. Fitzpatrick R, Bowling A, Gibbons E, Haywood K, Jenkinson C, Mackintosh A, et al., Patient-Reported Health Instruments Group. A Structured Review of Patient-Reported Measures in Relation to Selected Chronic Conditions, Perceptions of Quality of Care and Carer Impact Report to the Department of Health, United Kingdom, November 2006.

  16. Hirsch M, Donatucci C, Glina S, Montague D, Montorsi F, Wyllie M . Standards for clinical trials in male sexual dysfunction: erectile dysfunction and rapid ejaculation. J Sex Med 2004; 1: 87–91.

    Article  PubMed  Google Scholar 

  17. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A . The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822–830.

    Article  CAS  PubMed  Google Scholar 

  18. Cappelleri JC, Rosen RC, Smith MD, Quirk F, Maytom MC, Mishra A et al. Some developments on the International Index of Erectile Function (IIEF). Drug Inf J 1999; 33: 179–190.

    Article  Google Scholar 

  19. Rosen RC, Cappelleri JC, Gendrano N . The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res 2002; 14: 226–244.

    Article  CAS  PubMed  Google Scholar 

  20. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM . Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319–326.

    Article  CAS  PubMed  Google Scholar 

  21. Cappelleri JC, Rosen RC . The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience. Int J Impot Res 2005; 17: 307–319.

    Article  CAS  PubMed  Google Scholar 

  22. Lowly M, Collins S, Bloch MT, Gillman M, Lording DW, Sutherland P, et al., the QEQ Study Group. Quality of Erection Questionnaire correlates: change in erection quality with erectile function, hardness, and psychosocial measures in men treated with sildenafil for erectile dysfunction. J Sex Med 2007; 4: 83–92.

    Article  Google Scholar 

  23. Porst H, Gilbert C, Collins S, Hugna X, Symonds Stecher V, Hvidsten K . Development and validation of the Quality of Erection Questionnaire. J Sex Med 2007; 4: 372–381.

    Article  PubMed  Google Scholar 

  24. Althof SE, Corty EW, Levine SB, Levine F, Burnett AL, McVary K et al. EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology 1999; 53: 793–799.

    Article  CAS  PubMed  Google Scholar 

  25. Althof SE, Cappelleri JC, Shpilsky A, Stecher V, Diuguid C, Sweeney M et al. Treatment responsiveness of the Self-Esteem And Relationship (SEAR) questionnaire in erectile dysfunction. Urology 2003; 61: 888–893.

    Article  PubMed  Google Scholar 

  26. Cappelleri JC, Althof SE, Siegel RL, Shpilsky A, Bell SS, Duttagupta S . Development and validation of the Self-Esteem And Relationship (SEAR) questionnaire in erectile dysfunction. Int J Impot Res 2004; 16: 30–38.

    Article  CAS  PubMed  Google Scholar 

  27. Cappelleri JC, Symonds T . The Self-Esteem And Relationship questionnaire: an overview. Patient-Reported Outcomes Newsletter 2007; 38 (Fall issue): 19–22.

    Google Scholar 

  28. Mulhall JP, Levine LA, Jünemann KP . Erection hardness, a unifying factor for defining response in the treatment of erectile dysfunction. Urology 2006; 68 (Suppl 3A): 17–25.

    Article  PubMed  Google Scholar 

  29. Mulhall J, Althof S, Brock G, Goldstein I, Jünemann K-P, Kirby M . Erectile dysfunction: monitoring response to treatment in clinical practice—recommendations of an international consensus panel. J Sex Med 2007; 4: 448–464.

    Article  PubMed  Google Scholar 

  30. Mulhall JO, Goldstein I, Bushmakin A, Cappelleri JC, Hvidsten K . Validation of the erectile hardness score. J Sex Med 2007; 4: 1626–1634.

    Article  PubMed  Google Scholar 

  31. Mulhall JP, King R, Kirby M, Hvidsten K, Symonds T, Bushmakin AG et al. Evaluating the sexual experience in men: validation of the Sexual Experience Questionnaire. J Sex Med 2008; 5: 365–376.

    Article  PubMed  Google Scholar 

  32. Dorey G . Outcome measures for erectile dys: evaluation. Br J Nurs 2002; 11: 120–125.

    Article  PubMed  Google Scholar 

  33. Wincze J, Rosen R, Carson C, Korenman S, Niederberger C, Sadovsky R et al. Erection Quality scale: initial scale development and validation. Urology 2004; 64: 351–356.

    Article  PubMed  Google Scholar 

  34. Fisher WA, Brock G, Karlin G, Pommerville P, Huang XY, Bangerter K et al. Vardenafil improves erection quality assessed by the novel Erection Quality Scale in the broad population of men with erectile dysfunction. J Sex Med 2006; 3 (Suppl 3): 251–252.

    Google Scholar 

  35. DiBenedetti DB, Gondek K, Sagnier PP, Kubin M, Marquis P, Keininger D et al. The Treatment Satisfaction Scale: a multidimensional instrument for the assessment of treatment satisfaction for erectile dysfunction patients and their partners. Eur Urol 2005; 48: 503–511.

    Article  PubMed  Google Scholar 

  36. Swindle RW, Cameron AE, Lockhart DC, Rosen RC . The psychological and interpersonal relationship scales: assessing psychological and relationship outcomes associated with erectile dysfunction and its treatment. Arch Sex Behav 2004; 33: 19–30.

    Article  PubMed  Google Scholar 

  37. Woodward JM, Hass SL, Woodward PJ . Reliability and validity of the Sexual Life Quality Questionnaire (SLQQ). Qual Life Res 2002; 11: 365–377.

    Article  PubMed  Google Scholar 

  38. MacDonagh R, Ewings P, Porter T . The effect of erectile dysfunction on quality of life: psychometric testing of a new quality of life measure for patients with erectile dysfunction. J Urol 2002; 167: 212–217.

    Article  PubMed  Google Scholar 

  39. Latini DM, Penson DF, Colwell HH, Lubeck DP, Mehta SS, Henning JM et al. Psychological impact of erectile dysfunction: validation of a new health related quality of life measure for patients with erectile dysfunction. J Urol 2002; 168: 2086–2091.

    Article  PubMed  Google Scholar 

  40. Goldstein I, Kim E, Steers WD, Pryor JL, Wilde DW, Natanegara F et al. Efficacy and safety of tadalafil in men with erectile dysfunction with a high prevalence of comorbid conditions: results from MOMENTUS: Multiple Observations in Men with Erectile Dysfunction in National Tadalafil Study in the US. J Sex Med 2007; 4: 166–175.

    Article  CAS  PubMed  Google Scholar 

  41. Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH . Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999; 54: 346–351.

    Article  CAS  PubMed  Google Scholar 

  42. Cappelleri JC, Siegel RL, Osterloh IH, Rosen RC . Relationship between patient self-assessment of erectile function and the erectile function domain of the International Index of Erectile Function. Urology 2000; 56: 477–481.

    Article  CAS  PubMed  Google Scholar 

  43. NIH Consensus Panel on Impotence. Impotence. JAMA 1993; 270: 83–90.

    Article  Google Scholar 

  44. Rajpurkar A, Dhabuwala CB . Comparison of satisfaction rates and erectile function in patients treated with sildenafil, intracavernous prostaglandin E1 and penile implant surgery for erectile dysfunction in urology practice. J Urol 2003; 170: 159–163.

    Article  CAS  PubMed  Google Scholar 

  45. Eardley I, Wright P, MacDonagh R, Hole J, Edwards A . An open-label, randomized, flexible-dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men with erectile dysfunction. BJU Int 2004; 93: 1271–1275.

    Article  CAS  PubMed  Google Scholar 

  46. Mulhall JP, Ahmed A, Branch J, Parker M . Serial assessment of efficacy and satisfaction profiles following penile prosthesis surgery. J Urol 2003; 169: 1429–1433.

    Article  PubMed  Google Scholar 

  47. Levine LA, Latchamsetty KC . Treatment of erectile dysfunction in patients with Peyronie's disease using sildenafil citrate. Int J Impot Res 2002; 14: 478–482.

    Article  CAS  PubMed  Google Scholar 

  48. Raina R, Agarwal A, Goyal KK, Jackson C, Ulchaker J, Angermeier K et al. Long-term potency after iodine-125 radiotherapy for prostate cancer and role of sildenafil citrate. Urology 2003; 62: 1103–1108.

    Article  PubMed  Google Scholar 

  49. Montorsi F, Althof SE, Sweeney M, Menchini-Fabris F, Sasso F, Giuliano F . Treatment satisfaction in patients with erectile dysfunction switching from prostaglandin E1 intracavernosal injection therapy to oral sildenafil citrate. Int J Impot Res 2003; 15: 444–449.

    Article  CAS  PubMed  Google Scholar 

  50. Lewis R, Bennett CJ, Borkon WD, Boykin WH, Althof SE, Stecher VJ et al. Patient and partner satisfaction with Viagra (sildenafil citrate) treatment as determined by the Erectile Dysfunction Inventory of Treatment Satisfaction questionnaire. Urology 2001; 57: 960–965.

    Article  CAS  PubMed  Google Scholar 

  51. Cappelleri JC, Althof SE, Siegel RL, Stecher VJ, Tseng L-J, Duttagupta S . Association between the Erectile Dysfunction Inventory of Treatment Satisfaction and the Self-Esteem And Relationship questionnaire following treatment with sildenafil citrate for men with erectile dysfunction. Value Health 2005; 8 (Suppl 1): S54–S60.

    Article  PubMed  Google Scholar 

  52. Cappelleri JC, Bell SS, Althof SE, Siegel RL, Stecher VJ . Comparison between sildenafil-treated subjects with erectile dysfunction and control subjects on the Self-Esteem And Relationship questionnaire. J Sex Med 2006; 3: 274–282.

    Article  CAS  PubMed  Google Scholar 

  53. Cappelleri JC, Althof SE, O’Leary MP, Glina S, King R, Stecher VJ et al. Clinically meaningful improvement on the Self-Esteem And Relationship questionnaire in men with erectile dysfunction. Qual Life Res 2007; 16: 1203–1210.

    Article  PubMed  Google Scholar 

  54. Althof SE, O’Leary MP, Cappelleri JC, Hvidsten K, Stecher VJ, Glina S, et al., on behalf of the International SEAR Study Group. Sildenafil citrate improves self-esteem, confidence, and relationships in men with erectile dysfunction: results from an international, multi-center, double-blind, placebo-controlled trial. J Sex Med 2006; 3: 521–529.

    Article  CAS  PubMed  Google Scholar 

  55. O’Leary MP, Althof SE, Cappelleri JC, Crowley A, Sherman N, Duttagupta S, on behalf of the US SEAR Study Group. Self-esteem, confidence, and relationship satisfaction in men with erectile dysfunction treated with sildenafil citrate: a multicenter, randomized, parallel-group, double-blind, placebo-controlled study in the United States. J Urol 2006; 175: 1058–1062.

    Article  PubMed  Google Scholar 

  56. Althof SE, O’Leary MP, Cappelleri JC, Crowley AR, Tseng L-J, Collins S . Impact of erectile dysfunction on confidence, self-esteem, and relationship satisfaction after 9 months of sildenafil citrate. J Urol 2006; 176: 2132–2137.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Drs Cappelleri and Stecher are employees and shareholders of Pfizer Inc, the manufacturer of sildenafil. The development of the seven patient-reported outcomes detailed in this paper was sponsored by Pfizer Inc.

Author information

Authors and Affiliations

  1. Pfizer Inc, Global Research and Development, New London, CT, USA

    J C Cappelleri

  2. Pfizer Inc, New York, NY, USA

    V J Stecher

Authors
  1. J C Cappelleri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V J Stecher
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J C Cappelleri.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cappelleri, J., Stecher, V. An assessment of patient-reported outcomes for men with erectile dysfunction: Pfizer's perspective. Int J Impot Res 20, 343–357 (2008). https://doi.org/10.1038/ijir.2008.8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijir.2008.8

Keywords

This article is cited by

Search

Advanced search

Quick links